242 related articles for article (PubMed ID: 3310588)
1. Electrophysiology of Ethmozine (moricizine HCl) for ventricular tachycardia.
Wyndham CR; Pratt CM; Mann DE; Winkle RA; Somberg J; de Maria AN; Josephson ME
Am J Cardiol; 1987 Oct; 60(11):67F-72F. PubMed ID: 3310588
[TBL] [Abstract][Full Text] [Related]
2. Ethmozine: electrophysiology, hemodynamics, and antiarrhythmic efficacy in patients with life-threatening ventricular arrhythmias.
Dorian P; Echt DS; Mead RH; Lee JT; Lebsack CS; Winkle RA
Am Heart J; 1986 Aug; 112(2):327-33. PubMed ID: 3526852
[TBL] [Abstract][Full Text] [Related]
3. Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmias.
Hession MJ; Lampert S; Podrid PJ; Lown B
Am J Cardiol; 1987 Oct; 60(11):59F-66F. PubMed ID: 3310587
[TBL] [Abstract][Full Text] [Related]
4. Clinical, electrophysiologic and antiarrhythmic efficacy of moricizine HCl.
Smetnev AS; Shugushev KKh; Rosenshtraukh LV
Am J Cardiol; 1987 Oct; 60(11):40F-44F. PubMed ID: 3310584
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of moricizine in malignant ventricular arrhythmias.
Horowitz LN
Am J Cardiol; 1990 Feb; 65(8):41D-46D; discussion 68D-71D. PubMed ID: 1689535
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiologic effects of ethmozin in patients with ventricular tachycardia.
Mann DE; Luck JC; Herre JM; Magro SA; Yepsen SC; Griffin JC; Pratt CM; Wyndham CR
Am Heart J; 1984 Apr; 107(4):674-9. PubMed ID: 6367405
[TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
[TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic efficacy of ethmozine in patients with ventricular tachycardia as determined by programmed electrical stimulation.
Miura DS; Wynn J; Torres V; Laux B; Keefe D; Somberg JC
Am Heart J; 1986 Apr; 111(4):661-6. PubMed ID: 3513503
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of moricizine in patients with ventricular tachycardia: results of a placebo-controlled prospective long-term clinical trial.
Pratt CM; Wierman A; Seals AA; English L; Leon C; Young JB; Quinones MA; Roberts R
Circulation; 1986 Apr; 73(4):718-26. PubMed ID: 3512124
[TBL] [Abstract][Full Text] [Related]
10. Ethmozin. II. Effects of intravenous drug administration on atrioventricular nodal reentrant tachycardia.
Chazov EI; Rosenshtraukh LV; Shugushev KK
Am Heart J; 1984 Sep; 108(3 Pt 1):483-9. PubMed ID: 6382989
[TBL] [Abstract][Full Text] [Related]
11. Reproducibility of ventricular tachycardia suppression by antiarrhythmic drug therapy during serial electrophysiologic testing in coronary artery disease.
Garan H; Stavens CS; McGovern B; Kelly E; Ruskin JN
Am J Cardiol; 1986 Nov; 58(10):977-80. PubMed ID: 3776854
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiologic evaluation of pirmenol for sustained ventricular tachycardia secondary to coronary artery disease.
Easley AR; Mann DE; Reiter MJ; Sakun V; Sullivan SM; Magro SA; Luck JC; Wyndham CR
Am J Cardiol; 1986 Jul; 58(1):86-9. PubMed ID: 3728337
[TBL] [Abstract][Full Text] [Related]
13. Ethmozine (moricizine HCl): a promising drug for "automatic" atrial ectopic tachycardia.
Evans VL; Garson A; Smith RT; Moak JP; McVey P; McNamara DG
Am J Cardiol; 1987 Oct; 60(11):83F-86F. PubMed ID: 3310591
[TBL] [Abstract][Full Text] [Related]
14. Moricizine. A review of its pharmacological properties, and therapeutic efficacy in cardiac arrhythmias.
Fitton A; Buckley MT
Drugs; 1990 Jul; 40(1):138-67. PubMed ID: 2202581
[TBL] [Abstract][Full Text] [Related]
15. Meobentine sulfate: antiarrhythmic and electrophysiologic effects assessed by programmed electrical stimulation and ambulatory monitoring in patients with complex ventricular tachyarrhythmia. Report of a multicenter evaluation.
Anderson JL; Reid PR; Platia EV; Akhtar M; Ruskin JN; Schaal SF; Jueng P; Long RA; Wenger TL
Am Heart J; 1985 Oct; 110(4):774-84. PubMed ID: 3901715
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.
Roden DM; Lee JT; Woosley RL; Echt DS
Circulation; 1989 Nov; 80(5):1247-58. PubMed ID: 2805262
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiologic response to moricizine in patients with sustained ventricular arrhythmias.
Powell AC; Gold MR; Brooks R; Garan H; Ruskin JN; McGovern BA
Ann Intern Med; 1992 Mar; 116(5):382-7. PubMed ID: 1736771
[TBL] [Abstract][Full Text] [Related]
18. Cardioversion, defibrillation, and overdrive pacing of ventricular arrhythmias: the effect of moricizine in dogs with sustained monomorphic ventricular tachycardia.
Avitall B; Hare J; Zander G; Lessila C; Dhala A; Deshpande S; Jazayeri M; Sra J; Akhtar M
Pacing Clin Electrophysiol; 1993 Nov; 16(11):2092-7. PubMed ID: 7505920
[TBL] [Abstract][Full Text] [Related]
19. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
Veltri EP; Reid PR; Platia EV; Griffith LS
Am J Cardiol; 1985 Feb; 55(4):375-9. PubMed ID: 3969872
[TBL] [Abstract][Full Text] [Related]
20. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
